Genotyping Assays Market (Product & Service: Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics, and Technology: PCR, Microarrays, Sequencing, Capillary Electrophoresis, MALDI-TOF, and Others) - Global Industry Analysis, Size, Share, Gr

Genotyping Assays Market (Product & Service: Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics, and Technology: PCR, Microarrays, Sequencing, Capillary Electrophoresis, MALDI-TOF, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Genotyping Assays Market – Scope of Report

TMR’s report on the global genotyping assays market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global genotyping assays market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global genotyping assays market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the genotyping assays market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global genotyping assays market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global genotyping assays market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global genotyping assays market.

The report delves into the competitive landscape of the global genotyping assays market. Key players operating in the global genotyping assays market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global genotyping assays market profiled in this report.

Key Questions Answered in Global genotyping assays Market Report
  • What is the sales/revenue generated by genotyping assays across all regions during the forecast period?
  • What are the opportunities in the global genotyping assays market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Genotyping Assays Market – Research Objectives and Research Approach

The comprehensive report on the global genotyping assays market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global genotyping assays market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global genotyping assays market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Genotyping Assays Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Genotyping Assays Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Genotyping Assays Market Analysis and Forecast, by Product & Service
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product & Service, 2020-2034
6.3.1. Reagents & Kits
6.3.2. Genotyping Services
6.3.3. Instruments
6.3.3.1. Sequences & Amplifiers
6.3.3.2. Analyzers
6.3.4. Bioinformatics
6.3.4.1. Software
6.3.4.2. Services
6.4. Market Attractiveness, by Product & Service
7. Global Genotyping Assays Market Analysis and Forecast, by Technology
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2020-2034
7.3.1. PCR
7.3.1.1. Real-time PCR
7.3.1.2. Digital PCR
7.3.2. Microarrays
7.3.3. Sequencing
7.3.3.1. NGS
7.3.3.2. Pyrosequencing
7.3.3.3. Sanger Sequencing
7.3.4. Capillary Electrophoresis
7.3.4.1. Amplified Fragment Length Polymorphism
7.3.4.2. Restricted Fragment Length Polymorphism
7.3.4.3. Single-Stranded Conformation Polymorphism
7.3.5. MALDI-TOF
7.3.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
7.4. Market Attractiveness, by Technology
8. Global Genotyping Assays Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2034
8.3.1. Pharmacogenomics
8.3.2. Diagnostic & Personalized Medicine
8.3.3. Agricultural Biotechnology
8.3.4. Animal Genetics
8.3.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
8.4. Market Attractiveness, by Application
9. Global Genotyping Assays Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Pharmaceutical & Biopharmaceutical Companies
9.3.2. Diagnostic & Research Laboratories
9.3.3. Academic Institutes
9.3.4. Others (Animal and Aquagenetics Companies, etc.)
9.4. Market Attractiveness, by End-user
10. Global Genotyping Assays Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Genotyping Assays Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product & Service, 2020-2034
11.2.1. Reagents & Kits
11.2.2. Genotyping Services
11.2.3. Instruments
11.2.3.1. Sequences & Amplifiers
11.2.3.2. Analyzers
11.2.4. Bioinformatics
11.2.4.1. Software
11.2.4.2. Services
11.3. Market Attractiveness, by Product & Service
11.4. Market Value Forecast, by Technology, 2020-2034
11.4.1. PCR
11.4.1.1. Real-time PCR
11.4.1.2. Digital PCR
11.4.2. Microarrays
11.4.3. Sequencing
11.4.3.1. NGS
11.4.3.2. Pyrosequencing
11.4.3.3. Sanger Sequencing
11.4.4. Capillary Electrophoresis
11.4.4.1. Amplified Fragment Length Polymorphism
11.4.4.2. Restricted Fragment Length Polymorphism
11.4.4.3. Single-Stranded Conformation Polymorphism
11.4.5. MALDI-TOF
11.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
11.5. Market Attractiveness, by Technology
11.6. Market Value Forecast, by Application, 2020-2034
11.6.1. Pharmacogenomics
11.6.2. Diagnostic & Personalized Medicine
11.6.3. Agricultural Biotechnology
11.6.4. Animal Genetics
11.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Pharmaceutical & Biopharmaceutical Companies
11.8.2. Diagnostic & Research Laboratories
11.8.3. Academic Institutes
11.8.4. Others (Animal and Aquagenetics Companies, etc.)
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product & Service
11.11.2. By Technology
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Genotyping Assays Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product & Service, 2020-2034
12.2.1. Reagents & Kits
12.2.2. Genotyping Services
12.2.3. Instruments
12.2.3.1. Sequences & Amplifiers
12.2.3.2. Analyzers
12.2.4. Bioinformatics
12.2.4.1. Software
12.2.4.2. Services
12.3. Market Attractiveness, by Product & Service
12.4. Market Value Forecast, by Technology, 2020-2034
12.4.1. PCR
12.4.1.1. Real-time PCR
12.4.1.2. Digital PCR
12.4.2. Microarrays
12.4.3. Sequencing
12.4.3.1. NGS
12.4.3.2. Pyrosequencing
12.4.3.3. Sanger Sequencing
12.4.4. Capillary Electrophoresis
12.4.4.1. Amplified Fragment Length Polymorphism
12.4.4.2. Restricted Fragment Length Polymorphism
12.4.4.3. Single-Stranded Conformation Polymorphism
12.4.5. MALDI-TOF
12.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, by Application, 2020-2034
12.6.1. Pharmacogenomics
12.6.2. Diagnostic & Personalized Medicine
12.6.3. Agricultural Biotechnology
12.6.4. Animal Genetics
12.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Pharmaceutical & Biopharmaceutical Companies
12.8.2. Diagnostic & Research Laboratories
12.8.3. Academic Institutes
12.8.4. Others (Animal and Aquagenetics Companies, etc.)
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product & Service
12.11.2. By Technology
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Genotyping Assays Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product & Service, 2020-2034
13.2.1. Reagents & Kits
13.2.2. Genotyping Services
13.2.3. Instruments
13.2.3.1. Sequences & Amplifiers
13.2.3.2. Analyzers
13.2.4. Bioinformatics
13.2.4.1. Software
13.2.4.2. Services
13.3. Market Attractiveness, by Product & Service
13.4. Market Value Forecast, by Technology, 2020-2034
13.4.1. PCR
13.4.1.1. Real-time PCR
13.4.1.2. Digital PCR
13.4.2. Microarrays
13.4.3. Sequencing
13.4.3.1. NGS
13.4.3.2. Pyrosequencing
13.4.3.3. Sanger Sequencing
13.4.4. Capillary Electrophoresis
13.4.4.1. Amplified Fragment Length Polymorphism
13.4.4.2. Restricted Fragment Length Polymorphism
13.4.4.3. Single-Stranded Conformation Polymorphism
13.4.5. MALDI-TOF
13.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, by Application, 2020-2034
13.6.1. Pharmacogenomics
13.6.2. Diagnostic & Personalized Medicine
13.6.3. Agricultural Biotechnology
13.6.4. Animal Genetics
13.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Pharmaceutical & Biopharmaceutical Companies
13.8.2. Diagnostic & Research Laboratories
13.8.3. Academic Institutes
13.8.4. Others (Animal and Aquagenetics Companies, etc.)
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product & Service
13.11.2. By Technology
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Genotyping Assays Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product & Service, 2020-2034
14.2.1. Reagents & Kits
14.2.2. Genotyping Services
14.2.3. Instruments
14.2.3.1. Sequences & Amplifiers
14.2.3.2. Analyzers
14.2.4. Bioinformatics
14.2.4.1. Software
14.2.4.2. Services
14.3. Market Attractiveness, by Product & Service
14.4. Market Value Forecast, by Technology, 2020-2034
14.4.1. PCR
14.4.1.1. Real-time PCR
14.4.1.2. Digital PCR
14.4.2. Microarrays
14.4.3. Sequencing
14.4.3.1. NGS
14.4.3.2. Pyrosequencing
14.4.3.3. Sanger Sequencing
14.4.4. Capillary Electrophoresis
14.4.4.1. Amplified Fragment Length Polymorphism
14.4.4.2. Restricted Fragment Length Polymorphism
14.4.4.3. Single-Stranded Conformation Polymorphism
14.4.5. MALDI-TOF
14.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, by Application, 2020-2034
14.6.1. Pharmacogenomics
14.6.2. Diagnostic & Personalized Medicine
14.6.3. Agricultural Biotechnology
14.6.4. Animal Genetics
14.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Pharmaceutical & Biopharmaceutical Companies
14.8.2. Diagnostic & Research Laboratories
14.8.3. Academic Institutes
14.8.4. Others (Animal and Aquagenetics Companies, etc.)
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product & Service
14.11.2. By Technology
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Genotyping Assays Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product & Service, 2020-2034
15.2.1. Reagents & Kits
15.2.2. Genotyping Services
15.2.3. Instruments
15.2.3.1. Sequences & Amplifiers
15.2.3.2. Analyzers
15.2.4. Bioinformatics
15.2.4.1. Software
15.2.4.2. Services
15.3. Market Attractiveness, by Product & Service
15.4. Market Value Forecast, by Technology, 2020-2034
15.4.1. PCR
15.4.1.1. Real-time PCR
15.4.1.2. Digital PCR
15.4.2. Microarrays
15.4.3. Sequencing
15.4.3.1. NGS
15.4.3.2. Pyrosequencing
15.4.3.3. Sanger Sequencing
15.4.4. Capillary Electrophoresis
15.4.4.1. Amplified Fragment Length Polymorphism
15.4.4.2. Restricted Fragment Length Polymorphism
15.4.4.3. Single-Stranded Conformation Polymorphism
15.4.5. MALDI-TOF
15.4.6. Others (Allele-specific Oligonucleotide (ASO) Probes, Fluorescence In Situ Hybridization (FISH), etc.)
15.5. Market Attractiveness, by Technology
15.6. Market Value Forecast, by Application, 2020-2034
15.6.1. Pharmacogenomics
15.6.2. Diagnostic & Personalized Medicine
15.6.3. Agricultural Biotechnology
15.6.4. Animal Genetics
15.6.5. Others (Prenatal Testing, Human Forensics, Microbial Genomic Studies, Aquaculture Breeding Studies, etc.)
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Pharmaceutical & Biopharmaceutical Companies
15.8.2. Diagnostic & Research Laboratories
15.8.3. Academic Institutes
15.8.4. Others (Animal and Aquagenetics Companies, etc.)
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product & Service
15.11.2. By Technology
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Illumina, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Thermo Fisher Scientific
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. QIAGEN N.V.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Agilent
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Danaher Corporation
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Roche
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. GE HealthCare
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Standard BioTools Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. PerkinElmer
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Eurofins Scientific SE
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Bio-Rad Laboratories
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. Pacific Biosciences of California, Inc.
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. GENEWIZ, Inc.
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
16.3.14. Integrated DNA Technologies, Inc.
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Product Portfolio
16.3.14.3. Financial Overview
16.3.14.4. SWOT Analysis
16.3.14.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings